KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-cash Items: 2011-2017

Historic Non-cash Items for Emergent BioSolutions (EBS) over the last 3 years, with Sep 2017 value amounting to $38.0 million.

  • Emergent BioSolutions' Non-cash Items was N/A to $38.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $38.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2015, which is 903.38% up from last year.
  • Emergent BioSolutions' Non-cash Items amounted to $38.0 million in Q3 2017, which was up 2,467.83% from $1.5 million recorded in Q2 2016.
  • Over the past 5 years, Emergent BioSolutions' Non-cash Items peaked at $40.4 million during Q2 2015, and registered a low of $1.5 million during Q2 2016.
  • In the last 3 years, Emergent BioSolutions' Non-cash Items had a median value of $29.0 million in 2015 and averaged $23.3 million.
  • In the last 5 years, Emergent BioSolutions' Non-cash Items soared by 979.33% in 2013 and then crashed by 96.34% in 2016.
  • Emergent BioSolutions' Non-cash Items (Quarterly) stood at $23.1 million in 2013, then grew by 26.06% to $29.2 million in 2014, then plummeted by 31.46% to $20.0 million in 2015, then tumbled by 96.34% to $1.5 million in 2016, then reached $38.0 million in 2017.
  • Its last three reported values are $38.0 million in Q3 2017, $1.5 million for Q2 2016, and $38.0 million during Q1 2016.